Form 4 for HCAT Health Catalyst, Inc.
Accepted 2025-02-24 00:00:00 ET · period of report 2025-02-20 · accession 0001562180-25-001548 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-24 | 2025-02-20 | HCAT | Llewelyn Linda | CHRO | A - Grant | $0.00 | +80.8K | 166.4K | +94% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-20 | A | A | 69,000 | $0.00 | 154,819 | D | — | — | (F1) Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 33.33% of the RSUs will vest on December 1, 2025 and, thereafter, the remaining 66.67% of the RSUs will vest in 8 equal quarterly installments. |
| 2 | Common | Common Stock | 2025-02-20 | A | A | 11,750 | $0.00 | 166,369 | D | — | — | (F2) Represents an award of 11,750 performance-based restricted units ("PRSUs") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2024. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. (F3) Excludes 200 shares that were previously reported as held by the Reporting Person due to an inadvertent administrative error. |